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H I G H L I G H T S
• Numerous tools for gaming disorder (GD) have been developed in recent years.• We evaluated 32 GD tools and their evidence base from 320 empirical studies.• Several instruments had greater evidential support than others.• No single tool emerged as the clearly optimal choice.• A standard international tool would be invaluable to advance the GD field.
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A B S T R A C T
The inclusion of gaming disorder (GD) as an official diagnosis in the ICD-11 was a significant milestone for the
field. However, the optimal measurement approaches for GD are currently unclear. This comprehensive sys-
tematic review aimed to identify and evaluate all available English-language GD tools and their corresponding
evidence. A search of PsychINFO, PsychArticles, ScienceDirect, Scopus, Web of Science, and Google Scholar identified
32 tools employed in 320 studies (N=462,249 participants). The evaluation framework examined tools in
relation to: (1) conceptual and practical considerations; (2) alignment with DSM-5 and ICD-11 criteria; (3) type
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and quantity of studies and samples; and (4) psychometric properties. The evaluation showed that GD in-
strumentation has proliferated, with 2.5 tools, on average, published annually since 2013. Coverage of DSM-5
and ICD-11 criteria was inconsistent, especially for the criterion of continued use despite harm. Tools converge
on the importance of screening for impaired control over gaming and functional impairment. Overall, no single
tool was found to be clearly superior, but the AICA-Sgaming, GAS-7, IGDT-10, IGDS9-SF, and Lemmens IGD-9
scales had greater evidential support for their psychometric properties. The GD field would benefit from a
standard international tool to identify gaming-related harms across the spectrum of maladaptive gaming be-
haviors.
1. Introduction
Online gaming is a hundred-billion-dollar industry that continues to
innovate and expand on a global scale (King & Gaming Industry
Response Consortium, 2018). Individuals of all ages are motivated to
play games recreationally for relaxation, challenge, and socialization
(Yee, 2006). While there are benefits associated with gaming (Granic,
Lobel, & Engels, 2014), unrestricted gaming may be highly absorbing
and time-consuming, and may become addictive for vulnerable in-
dividuals (Brand et al., 2016; Higuchi et al., 2017; King et al., 2019;
King et al., 2019; Sim, Gentile, Bricolo, Serpollini, & Gulamoydeen,
2012). Over the last three decades, increasingly accumulated research
and clinical evidence has supported recognizing the most severely
maladaptive forms of gaming behavior as an addictive disorder (Baggio
et al., 2016; Feng, Ramo, Chan, & Bourgeois, 2017; Khazaal et al., 2016;
King & Delfabbro, 2019a; King & Delfabbro, 2019b; Meng, Deng, Wang,
Guo, & Li, 2015; Mihara & Higuchi, 2017; Müller et al., 2015; Rehbein,
Kliem, Baier, Mößle, & Petry, 2015; Rumpf et al., 2018; Scharkow,
Festl, & Quandt, 2014; van Rooij et al., 2012; Yao et al., 2017). How-
ever, despite the recognition of gaming disorder (GD), there remains
uncertainty regarding optimal approaches to screening and assessment.
This uncertainty is due, in part, to the many available, similarly named
but varied measurement tools for the condition. To help inform the next
phase of research on this new disorder, wherein lies an opportunity for
researchers to collaborate and adopt a more consistent approach, the
aim of this review was to critically evaluate all available GD tools and
their corresponding evidence.
Following a provisional status for ‘internet gaming disorder’ (IGD)
in the DSM-5 (American Psychiatric Association, 2013), gaming dis-
order was officially adopted at the World Health Assembly in May 2019
as a diagnosis in the eleventh edition of the International Classification
of Diseases (ICD-11; WHO, 2019). GD is characterized by persistent
gaming behavior, impaired control over gaming, and functional im-
pairment due to gaming for a period of at least 12months in most in-
stances (Saunders et al., 2017). Individuals with GD play games to the
exclusion of other activities, resulting in missed life opportunities and
interference with normal routine and basic self-care (i.e., sleep, eating,
personal hygiene); real-world social interaction (i.e., meeting friends,
visiting family); and important responsibilities (i.e., school, work, care
of children) (Allison, Von Wahlde, Shockley, & Gabbard, 2006;
Beranuy, Carbonell, & Griffiths, 2013; Griffiths, 2010). Individuals with
GD often feel unable to regulate or cease their gaming behavior, and
experience intense negative mood states (e.g., irritability, sadness, and
boredom) when unable to play (Dong, Wang, Du, & Potenza, 2017;
Kaptsis, King, Delfabbro, & Gradisar, 2016). Personal distress may also
relate to a fear of missing out on the online game world, where the user
feels a strong sense of personal identity and self-efficacy (King &
Delfabbro, 2014; Lemenager et al., 2013; Marino & Spada, 2017;
Wegmann, Oberst, Stodt, & Brand, 2017). With the official inclusion of
GD as a diagnostic category in the ICD-11, it was considered timely to
evaluate the extent to which current instruments were consistent with
current defining elements of GD.
Previous reviews and related articles on GD instrumentation have
reported various inconsistencies and psychometric weaknesses
(Griffiths, King, & Demetrovics, 2014; King, Delfabbro, Zwaans, &
Kaptsis, 2013; King, Haagsma, Delfabbro, Gradisar, & Griffiths, 2013;
Lortie & Guitton, 2013; Petry et al., 2014; Starcevic, 2013). The most
recent major systematic review examined 18 assessment tools em-
ployed in 63 studies and reported problems including inconsistent cut-
off scores and symptom coverage, and inadequate data on predictive
validity and inter-rater reliability (King, Haagsma, et al., 2013). Un-
certainty has also arisen due to the common research practice of
adapting or developing new tools rather than using previous ones. Prior
to the provisional DSM-5 criteria for GD, researchers would often adapt
the criteria of other disorders (e.g., pathological gambling in the DSM-
IV-TR) (Fisher, 1994; Griffiths & Hunt, 1998). Over time, this practice
evolved into adapting these criteria in new ways (e.g., word edits or
substitutions, new response categories) and combining other previous
items, sometimes sourced from three or more different scales, with new
items to create composite measures (e.g., Groves, Gentile, Tapscott, &
Lynch, 2015; Jap, Tiatri, Jaya, & Suteja, 2013; Peng & Liu, 2010).
Inconsistent and/or inadequate measurement of GD has major im-
plications for the quality of its research base, as well as for the allo-
cation of clinical and public health resources to address social problems
arising from GD. Epidemiological studies that employ short screening
tools are relied upon to inform policy decisions and therefore must
provide a valid indication of the problem. Epidemiological research on
problematic gaming and GD has often been criticized for its sampling
approaches, such as recruiting gamers from online gaming forums or
sampling a limited pool of students from local schools or universities
(van Rooij et al., 2018). However, the psychometric properties of
measurement tools in GD studies have received relatively less critical
attention. In recent years, there has been an increase in population
cohort studies of GD, as well as many large-scale studies (e.g., the
Longitudinal Cohort Study on Substance Use Risk Factors [C-SURF] of
young men in Switzerland) that have incorporated gaming-related
questions. For example, Rehbein et al. (2015) conducted a state-re-
presentative school survey of 11,003 adolescents aged 13 to 18 years
using the DSM-5 criteria for GD and reported a 1.2% prevalence of GD.
A study by Müller et al. (2015) examined GD in seven European
countries based on a representative sample of 12,938 adolescents be-
tween 14 and 17 years, reporting that 1.6% of the sample met the cri-
teria for IGD, with a further 5.1% at risk for GD by meeting up to four
criteria. Other studies have reported comparable figures, including:
0.6% of 816 Norwegian adolescents (Mentzoni et al., 2011); between
0.3 and 1.0% in four international cohorts totalling 18,932 people
(Przybylski, Weinstein, & Murayama, 2016); 2.0% in a sample of 1718
Chinese adolescents (Mak et al., 2014); 1.3% in a nationally re-
presentative panel of 902 Dutch gamers (Haagsma, Pieterse, & Peters,
2012); 1.5% of Dutch adolescents (van Rooij, Schoenmakers, Vermulst,
Van Den Eijnden, & Van De Mheen, 2011); and 1.8% of 1287 Australian
adolescents (King, Delfabbro, et al., 2013; King, Haagsma, et al., 2013).
These figures appear to be comparable with prevalence estimates re-
ported for other similar conditions, such as gambling disorder (Calado
& Griffiths, 2016). However, there have also been numerous studies of
GD that have reported much higher prevalence figures, including rates
in excess of 15–20% which seem to defy logic (Seok & DaCosta, 2012;
Wang et al., 2014; Xin et al., 2018) and raise concerns about the va-
lidity of instrumentation and associated risks such as false positives.
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1.1. The present review
The present review aimed primarily to evaluate all available GD and
related instruments and their associated empirical evidence base.
Although numerous tools refer to IGD in their name and/or source pub-
lication, which is the construct used in the DSM-5, this review uses the
abbreviation GD to encompass both the DSM-5 and ICD-11 classifications,
including when referring to all tools and constituent items. A secondary
aim of this review was to provide insights into the nature and quality of
the overall evidence base on GD. This evaluation was guided by a similar
previous major review conducted by King, Haagsma, et al., 2013 prior to
the inclusion of IGD as a condition for further study in the DSM-5. It was
reasoned that the 2013 review should be updated given that new data may
often inform a new consensus on a topic, particularly in a rapidly changing
field. The Cochrane Collaboration, for example, recommends that sys-
tematic reviews are updated every two years (Moher et al., 2008).
The 2013 systematic review was informed by standards in psycho-
logical assessment (Cicchetti, 1994; Groth-Marnat, 2009), which were
incorporated into the new framework for the present review. The 2013
review highlighted some of the conceptual inconsistencies across GD
tools, as well as gaps in empirical evidence underlying available mea-
sures' psychometric properties. In addition to describing the conceptual
and practical considerations of all GD tools, the present review sought
to address basic questions of: (1) whether current tools were consistent
with the DSM-5 and ICD-11 criteria; (2) which tools were being used in
which specific research areas (i.e., epidemiological, neurobiological,
interventions); and, (3) which tools had received relatively greater
evidential support for their psychometric properties.
2. Methods
2.1. Identification and selection of tools
This review aimed to identify and examine all available instruments
for screening or assessing problematic gaming and/or GD. Tools were
selected for inclusion if they met the following criteria: (1) peer-re-
viewed and published in English language; (2) accessibility of all test
items and response categories (e.g., list in appendix section, or analysis
of test items, e.g., factor analysis); (3) primarily designed to measure
problematic gaming or gaming disorder, and not internet addiction or
other condition (NB: an exception was made for widely used internet
addiction tests that refer specifically to gaming activities, e.g., the
Young Internet Addiction Test [YIAT; Young, 1998] and Compulsive
Internet Use Scale (CIUS; Meerkerk, Van Den Eijnden, Vermulst, &
Garretsen, 2009), and for the Screener for Substance and Behavioral
Addictions [SSBA; Schluter, Hodgins, Wolfe, & Wild, 2018] as a beha-
vioral addiction tool); (4) the test was self-report (i.e., not completed by
an external rater, e.g., parent); and, (5) the test was original and not a
composite of two or more existing measures and/or adapted DSM or
other diagnostic criteria (e.g., alcohol-use disorder criteria adapted to
gaming). A database search was conducted on 4 April 2019 by the first
author (DLK). The Google Scholar and academic databases, including
PsychINFO, PsychArticles, PubMed, ScienceDirect, Scopus, and Web of
Science, were searched using the following keywords and protocol:
((measure or tool or test or validation or psychometric or screening or
diagnostic or item or instrument) AND gaming). Fig. 1 presents a
PRISMA summary of the database search that yielded a total of 5828
Scopus
1,578
ScienceDirect
219
Web of Science
423
PsychINFO
1,469
PsychArticles
508
Google Scholar
17,800
Academic search
5,828
23,628
titles screened
1,191 excluded for 
non-source material 
for GD tool
1,335
potentially 
eligible papers
144 potentially 
eligible papers
Google Scholar 
citations
(N=12,996)
TOTAL: 320 studies
eligible for inclusion
TOTAL: 32 tools
eligible for inclusion 
112 papers 
did not meet 
inclusion 
criteria
12,676 papers 
excluded for non-
relevant topic or non-
empirical research
PubMed
1,631
Fig. 1. Search results and tool selection in accordance with PRISMA guidelines.
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results (including duplicate results). The titles and abstracts of all re-
sults generated by each database were screened for relevance using the
above inclusion criteria, which led to the identification of 32 tools,
including tests with multiple item formats (see Table 1 for the complete
list).
2.2. Identification of empirical literature underlying tools
The second phase of the search protocol involved identifying all
empirical studies that have employed at least one of the identified 32
tools. This search protocol involved a procedural examination of the
Google Scholar citation records for all identified tools (as of April 2019).
Google Scholar was used because it is rapidly updated to include new
results across multiple academic databases. Table 3 provides a summary
of the citation records for each tool; citation counts were highly vari-
able and ranged between no citations and 5413 citations. The total
citation count for all tools combined was 12,996 (NB: papers citing a
paper that presented multiple versions of a tool were counted only
once). These records were examined to identify empirical studies pub-
lished in English. There were no restrictions on inclusion of studies
based on study type (e.g., intervention, epidemiological, neurobiolo-
gical), publication date, or any potential methodological shortcomings.
However, articles that were not peer-reviewed (e.g., dissertation ma-
terial, conference proceedings) were excluded. Supplementary material
1 presents a numbered list of 328 references, with each number cor-
responding to the evidence cited in superscript format in Tables 5 and
6.
2.3. Tools evaluation framework
This review aimed to provide a comprehensive descriptive summary
and critical evaluation of the conceptual and psychometric properties,
and practical considerations, of all 32 identified tools. This evaluation
was conducted in stages under the guidance and collaboration of
members of the research team, which was composed of 14 experts (i.e.,
psychiatrists, research professors, psychometrician, clinical psycholo-
gists) in the field of GD and behavioral addictions. This review was
informed by the structure and protocols of the previous systematic re-
view of GD tools conducted by King, Haagsma, et al., 2013. The 2013
review was based on 18 tools (N=63 studies) published up to 2012,
and therefore preceded the DSM-5 and ICD-11 recognition of GD (NB:
the DSM-5 has only recognized IGD as a provisional disorder, or con-
dition in need of further study). The present review sought to address
the question of whether available tools were consistent with, and cap-
able of, assessing IGD/GD as described in the DSM-5 and ICD-11 clas-
sifications. The 2013 framework was guided by JARS reporting stan-
dards (APA Publications and Communications Board Working Group,
2008), as well as Cicchetti's (1994) and Groth-Marnat's (2009) criteria
and guidelines for evaluating psychological tests.
The present review aimed to incorporate the 2013 review's frame-
work components, as well as extend the previous review by including
more advanced psychometric information. All tools and studies eval-
uated in this review (i.e., the master spreadsheets underlying all ana-
lyses in this review, which were created by DLK) were checked by at
least 3 members of the research team (i.e., JB, NC, and PHD). Any
discrepancies or errors in ratings or data entry were resolved by con-
sultation among authors. At every stage of the review process, all
members of the research team were provided with relevant updates and
documentation outlining the procedures and results. All members were
invited to contribute any feedback or other observations on this mate-
rial. All feedback and suggestions were responded to as team messages
for transparency. As explained in Section 2.3.4, there was a roundtable
discussion attended in person by 11 team members at the 6th Inter-
national Conference on Behavioral Addictions in Yokohama, Japan,
which enabled discussion of the review's content (distributed electro-
nically before the meeting) and reach consensus decisions on how toTa
bl
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present this information in tabular format for a final report.
2.3.1. Review framework I: overview
First, all 32 tools were summarized according to the following basic
characteristics: (1) tool abbreviation (i.e., tool acronym or short-hand
name; some tools were disambiguated by using new terms, e.g., ‘Petry
IGD’ and ‘Lemmens IGD’ to minimize potential confusion with other
scales with IGD as their namesake); (2) author and date (derived from
original publication source); (3) tool components (i.e., constructs re-
portedly measured by the tool); (4) number of items (i.e., all tool items),
including those which may not be included in scoring considerations
(e.g., the AICA-Sgaming and C-VAT2.0 include additional items for
clinical judgement but are not scored); (5) response format (i.e., re-
sponse options for tool items, e.g., yes/no); (6) cut-off score (i.e., cut-off
for ‘problematic’ or ‘addicted’ status on the test, based on original
source reference, if reported); (7) age (i.e., participant with the lowest
age who completed the tool in the original study); (8) country of origin
(i.e., country of research team's institution, with priority given to first
author); and, (9) language versions (i.e., known language versions of the
tool, based on the published evidence base only).
2.3.2. Review framework II: DSM/ICD coverage
The second step involved evaluation of each tool's coverage of the
DSM-5 and ICD-11 criteria for IGD/GD. Variation in coverage of criteria
or guidelines is important because it may, for example, affect pre-
valence rates in epidemiological studies or affect diagnostic specificity
in clinical practice. At the same time, it is acknowledged that total
coverage of DSM/ICD criteria is not essential for the purpose of
screening, where having fewer items is considered more feasible for the
purpose of obtaining insights into, or estimates of, potential harms.
Each test's description of its components (i.e., symptoms) were com-
pared to each of the criteria in their respective DSM-5 and ICD-11 ca-
tegories. The DSM-5 criteria included 9 symptoms (see American
Psychiatric Association, 2013); the ICD-11 guidelines included 3 cri-
teria (i.e., 1: impaired control, 2: increasing priority given to gaming; 3:
continuation of gaming despite harm; see WHO, 2019) and then func-
tional impairment which was delineated into 5 main areas (i.e., per-
sonal [psychological/physical well-being], social, education, work, and
financial). The Table 2 legend provides further information on each
type of impairment. The rationale for delineating impairment types was
to identify tools that may provide contextually useful information on
gaming-related consequences, such as greater applicability to certain
investigations (e.g., studies of social correlates of gaming) or special
populations (e.g., school-related consequences of excessive gaming).
2.3.3. Review framework III: quantifying the evidence base
The third step of the evaluation involved a detailed summary of the
empirical evidence base for all 32 tools. The evidence was summarized
according to: (1) Google Scholar citation count (i.e., all citations, irre-
spective of publication type); (2) Number of empirical studies (i.e., stu-
dies that employed the tool, excluding any non-quantitative studies);
(3) Validation studies (i.e., studies that involved tool validation based on
nationally representative or clinical samples, delineating studies ac-
cording to those conducted by: (i) the tool's original author, and (ii)
independent research teams); (4) Intervention studies (i.e., studies in-
volving any type of intervention, e.g., psychotherapy, prevention); (5)
Clinical sample (i.e., participants with diagnosed GD or probable GD
using a structured clinical interview by a psychiatrist, clinical psy-
chologist, or qualified registrar; participants seeking treatment for GD;
and both aforementioned scenarios); (6) Longitudinal studies (i.e., stu-
dies with repeated observations of the same sample, with no restriction
on intervals between observations); (7) Prevalence studies (i.e., studies
yielding a GD prevalence rate based on a nationally representative
sample or subsample [e.g., adolescents] of the population), and; (8)
Neurobiological studies (i.e., studies that employ imaging technologies,
such as functional magnetic resonance imaging (fMRI), and/or
neurocognitive measures). In addition, a descriptive summary of the
samples' size and age composition, and recruitment approaches, asso-
ciated with each tool was generated. The review framework delineated:
(1) Total N (i.e., the total number of participants who have been ad-
ministered the tool across all studies); (2) Participant age (i.e., adoles-
cent [<18 years] vs. adult age); and (3) recruitment strategy (i.e., con-
venience vs non-convenience sampling). This information was then
used to calculate the relative proportion of age groups and convenience
sampling for each tool.
2.3.4. Review framework IV: psychometric properties of tools
The fourth step of the review summarized the research evidence on
each test's psychometric properties. The broad aim was to determine
the nature, quantity, and overall consistency of research support for
each tool's validity and reliability. Applying the framework published
by King, Haagsma, et al., 2013, and extending this framework to con-
sider new areas of test refinement and clinical utility, this undertaking
considered the following areas for evaluation: (1) Dimensionality (i.e.,
type of statistical analysis, e.g., exploratory factor analysis; results, e.g.,
1-factor solution); (2) Reliability (i.e., internal consistency, test-retest
coefficients); (3) Refinement (i.e., results of Rasch analysis, item re-
sponse theory [IRT], measurement invariance); (4) Validity (i.e., con-
vergent, criterion); (5) Relationship to impairment (i.e., association with
recognized measure of functional impairment); and, (6) Clinical use
(i.e., known utility within a clinical interview; use as an outcome
measure for a structured intervention).
Information on each of the above psychometric areas was extracted
by systematic review of each of the 328 articles for compilation into
Excel spreadsheets. This process was assisted by the advanced search
function in Acrobat Reader DC to identify relevant keywords. For ex-
ample, the keyword ‘factor’ was used to identify all factor analyses
reported across the 328 studies. Identification and registration of many
of these areas involved a simple transposition of a numerical value (e.g.,
Cronbach's alpha, or a bivariate correlation from a table). For test areas
that involved interpretation of statistical analysis (i.e., Rasch, IRT,
measurement invariance), the lead author was assisted by an experi-
enced senior psychometrician (NC) who confirmed or clarified the re-
ported results and interpretation (e.g., consistency of reporting with
statistical results, such as correct handling of root mean square of ap-
proximation [RMSEA] values). All values and interpretation were
compiled into a master spreadsheet for review and consultation by co-
authors.
2.3.5. Synthesis of review findings
Given the volume of information yielded for each tool, a final
summary table was created to provide a parsimonious overview and
comparison of the 32 tools. The primary purpose of this table was to
provide readers with a quick reference guide for each tool, which may
guide decision-making regarding the utility of each tool for particular
uses. The framework for this table was developed by a roundtable
discussion involving 11 authors (DLK, SC, JB, KM, MNP, HJR, JS, VS,
ZD, MB and SH) and subsequently discussed and approved by all au-
thors. The Table 7 legend provides a complete explanation of the
components and scoring information. The scoring rubric was generated
for each area to summarize the quantity and/or consistency of research
evidence, where applicable. For example, a score of 0 referred to the
absence of research evidence; a score of 1 indicated that only 1 study
was available, and; a score of 2 indicated that 2 or more studies were
available. For reliability indices, a study reporting a value of 0.70 or
above was considered generally sufficient for inclusion (Cronbach,
1951; Lance, Butts, & Michels, 2006; Schmitt, 1996), acknowledging
the caveats of this cut-off, e.g., that longer scales tend to have higher
alphas (Cicchetti, 1994; Groth-Marnat, 2009). For criterion and con-
vergent validity, an association of 0.3 or above was the cut-off (i.e.,
moderate; Cohen, 1992). Scoring was not weighted and thus does not
necessarily reflect the overall quality (i.e., validity, reliability, utility) of
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Table 2
Coverage of DSM-5 and ICD-11 gaming disorder criteria across all tools (N=32).
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PVP Scale 7 3
A-EQ 5 3
GAS-7 7 3
GAS-21 8 3
POGU 3 3
AICA-Sgaming 7 2
POGQ 5 3
VAT 5 3
POGQ-SF 5 3
sIAT-gaming 6 3
IGD-20 8 3
GAIA 5 3
Petry IGD 9 4
IGDS9–SF 9 4
Lemmens IGD-9 8 3
Lemmens IGD-27 8 3
GAIT 6 3
CSAS 7 3
PIE-9 9 4
BAM-VG 7 3
IGDT10 9 4
SCI-IGD 9 4
VASC 4 2
C-VAT2.0 9 4
IGUESS 9 4
DIA 9 4
YIAT 6 3
YDQ 7 2
CIUS-14 6 3
CIUS-8 4 3
CIUS-5 2 3
SSBA 2 1
Note: assessed; not assessed. NB: See Table 1 for full test names. Underlined values represent full coverage of respective criteria.
1Refers to total DSM-5 criteria covered by test (max. 9).
2Refers to total ICD-11 criteria covered by test (max 4); NB: 1 point for any specific impairment items (listed below).
Impairment types:
Personal: Sleep, appetite, well-being due to excessive use, basic hygiene, other health-related issues.
Social: Relationship conflict/interference, neglect, includes relationships with partner, children, other family members, and friends.
Education: Conflict/interference/disruption, neglect, loss of educational [school/university/learning] opportunities, productivity, outcomes.
Work: Conflict/interference/disruption, neglect, loss of occupational [paid/volunteer work] opportunities, productivity, outcomes.
Financial: Problems related to spending too much money on gaming activities.
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each tool. Some tools with relatively more highlighted areas may have
other specific deficiencies that make them less suitable than other tools.
Some tools with fewer highlighted areas may simply reflect that the tool
is more recent and therefore has less supporting evidence.
3. Results
3.1. Overview of tools
Table 1 presents a summary of all 32 tools, including original re-
ferences and countries of origin, tool components, items, scoring in-
formation, and language versions. The tools have been presented in
ascending order of publication date, with the non-gaming-specific tools
(n=6) positioned separately at the end of the list. This order is used
consistently for all tables except for Table 4, which is re-ordered to
match the distribution of total N data in cells (i.e., descending fre-
quencies) for ease of comprehension.
Inspection of the list of tools and author information shows that
some researchers (and/or their respective research teams) have created
or contributed to the development of more than one tool. For example,
Mark Griffiths (UK) is a named contributor on 5 tools (including 1 short
version); Jeroen Lemmens (the Netherlands) is named on 5 tools (in-
cluding 2 tools with extended versions); and Tony van Rooij (the
Netherlands) is named on 2 tools. The most common country of origin
was The Netherlands (n=7), followed by South Korea and Germany
(n=4 each), and then the United States, United Kingdom, and Hungary
(n=3 each). Most tools used continuous response categories, with the
most common type being a 5-point scale (n=16). Only 9 tools employ
“Yes/No” responses. Most tools (n=22) reported a cut-off score, and
most tools (n=29) were reportedly suitable for respondents under the
age of 18 years; however, the minimum age varied (n=15 specified
12–13 years of age). Most tools (n=29) were available in non-English
languages. Overall, 29 different languages were represented.
3.2. Coverage of DSM-5 and ICD-11 criteria
Table 2 presents a summary of all tools' coverage of the DSM-5 and
ICD-11 criteria. This evaluation referred to the 9 criteria for DSM-5 IGD
(i.e., preoccupation, withdrawal, tolerance, unsuccessful attempts to
stop/limit, loss of interests due to gaming, continued use despite harm,
deception, escape, and harm) and the 3 guidelines for ICD-11 GD
(6C51) (i.e., impaired control, increasing priority to gaming, and con-
tinued use despite harm) and functional impairment (see Section 2.2).
This evaluation showed that, overall, there was inconsistent symptom
coverage across the 32 tools. With regard to the DSM-5 criteria, the
most consistent criterion (n=31 tools; 97%) was “9: Has jeopardised or
lost a significant relationship, job, or educational or career opportunity due
to gaming.” Other common criteria were symptoms 1 (preoccupation), 2
(withdrawal), 3 (unsuccessful attempts), and 8 (escape), with at least 27
tools including each symptom. Only 9 tools included symptom 6 (con-
tinued use despite harm). In total, only 8 tools provided coverage of all 9
DSM-5 criteria (i.e., Petry IGD, IGDS9-SF, PIE-9, IGDT-10, CVAT2.0,
Table 3
The empirical evidence base for reviewed tools for problematic gaming and gaming disorder.
Instrument Citations Studies Validata Interv. Clinical sample Long. Prev. Neurobiological
SDI T-S SDI & T-S Imaging Cognitive
PVP Scale 494 22 – – – 2 – – 7 – 2
A-EQ 798 17 – – – – – 1 2 – –
GAS-7 665 45 6;6 – – – – 12 18 1 3
GAS-21 665 16 – – – – – 2 1 – –
POGU 144 2 – 1 – – 1 – – – –
AICA-Sgaming 55 18 3;1 1 – 1 10 – 5 3 –
POGQ 155 8 – – – – – – – – 2
VAT 83 7 1;0 1 – – – – 3 1 –
POGQ-SF 78 6 1;0 – – – – – 2 – 1
sIAT-gaming 153 8 – – – – – – – – –
IGD-20 150 8 – 1 – – 2 – – – –
GAIA 15 1 – – – – – – – – –
Petry IGD 445 13 – – 4 1 – – – 4 1
IGDS9–SF 152 24 1;0 – 2 – – 2 3 – –
Lemmens IGD-9 186 16 1;0 – – – – 4 4 – –
Lemmens IGD-27 186 2 1;0 – – – – – 1 – –
GAIT 15 4 – – – 1 – 1 3 – –
CSAS 12 2 – – – – – – 2 – –
PIE-9 10 3 – – – – – – – – –
BAM-VG 13 2 – – – – – 1 – – –
IGDT-10 68 7 1;1 – – – – – 1 – –
SCI-IGD 14 1 1;0 – 1 – – – – – –
VASC 7 1 – – – – – – – – –
C-VAT2.0 40 1 1;0 – – – 1 – – – –
IGUESS 6 4 2;0 – 2 – – – 1 – –
DIA – 1 – – 1 – – – – – –
YIAT 2387 62 – 9 23 – 16 5 2 24 3
YDQ 5413 12 1;1 1 – – 4 2 7 – 2
CIUS-14 580 12 4;2 – 1 – – – 7 – 1
CIUS-8 – 1 1;0 – 1 – – – – – –
CIUS-5 5 1 1;0 – – – – – 1 – –
SSBA 2 1 – – – – – – 1 – –
Total 12,996 328 26;11 14 35 5 34 30 71 33 15
Interv: Intervention studies. Long: Longitudinal studies. Prev: Prevalence studies. SDI: Structured/semi-structured diagnostic interview. T-S: Treatment-seeking
sample. NB: 328 studies due to duplicated entries for papers with multiple tests and studies (study 1, study 2, etc).
Underlined: Most frequent in column.
a Validation samples, where the first value is the number of studies using nationally representative or clinical samples, and the second value in the total number of
independent studies (i.e., studies not conducted by test author).
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IGUESS, and DIA).
With regard to ICD-11 GD guidelines, all 32 tools including at least
one item for “1: impaired control over gaming.” Most tools (n=28)
measured “2: Increasing priority given to gaming to the extent that gaming
takes precedence over other life interests and daily activities.” As noted for
the DSM-5 criteria, only 9 tools included the ICD-11 criterion “3:
Continuation or escalation of gaming despite the occurrence of negative
consequences.” Coverage of specific types of functional impairment was
inconsistent. Consistent with King, Haagsma, et al., 2013 findings, the
most common type of impairment referred to negative social con-
sequences (n=30), followed by negative personal (n=20) and occu-
pational (n=18) consequences. Only 5 tools referred to negative fi-
nancial consequences of gaming (e.g., debt, overspending on game
content; see Brooks & Clark, 2019; Zendle & Cairns, 2018, 2019). In
total, only 3 tools provided coverage of all 3 ICD-11 guidelines and 4
domains of functional impairment (i.e., Petry IGD, PIE-9, and IGDT-10),
and an additional 4 tools covered all 3 ICD-11 guidelines and 3 domains
of functional impairment (i.e., IGDS9-SF, SCI-IGD, CVAT2.0, and DIA).
Overall, there were 8 tools that provided total coverage of both the
DSM-5 and ICD-11 criteria (i.e., Petry IGD, IGDS9-SF, PIE-9, IGDT-10,
SCI-IGD, CVAT2.0, IGUESS, and DIA). Of this list, only 3 tools referred
to 4 types of functional impairment (i.e., Petry IGD, PIE-9, and IGDT-
10).
3.3. The evidence base underlying GD tools
Table 3 summarizes the empirical research literature (n=320 stu-
dies, excluding duplicates) that have employed at least one of the 32 GD
tools (NB: Supplementary material 1 presents a list of 328 references,
which includes 8 duplicated references (i.e., refs 16–93, 19–95, 39–83,
48–177, 82–84, 88–129, 195–212, 196–213)); this duplication occurred
during coding phases to disambiguate studies with more extensive in-
formation on multiple GD tools and/or study parts (i.e., Study 1, Study
2) to ensure that these data were cross-checked properly prior to en-
tering into master spreadsheets.
This evaluation provides an overview of a substantial proportion of
the empirical GD literature (NB: it was beyond the scope of this review
to estimate the overall size of the total empirical GD literature; i.e.,
including other studies that employ an unnamed or uncited instru-
ment). Table 3 indicates that the GD field has at least 30 longitudinal
studies, 71 prevalence studies (i.e., studies that employ nationally re-
presentative samples), and 14 intervention studies. Overall, the most
frequently used tools, irrespective of study type, were the YIAT
(n=62), GAS-7 (n=45), and IGDS9-SF (n=24). The most common
tool used in prevalence studies was the GAS-7 (n=18), which was also
the most common tool for longitudinal studies (n=12). The YIAT has
been used in 39 intervention studies and reports on treatment-seekers at
baseline, with the majority (n=37) conducted in China and South
Korea.
The YIAT and YDQ are the most cited tools, which may be due to
their prescience (i.e., these tools are presented in papers by the late
Kimberly Young, a pioneer of the field of internet addiction; Brand &
Potenza, 2019) and their earlier publication relative to other tools in
the review. The Petry IGD tool is highly cited (n=447) relative to its
use in studies (n=16), which may be due to being cited for its re-
ference to international “consensus” on gaming disorder (i.e., many of
its citations include commentary and debate papers on the topic of
consensus on DSM-5 IGD). Similarly, the A-EQ is highly cited (n=798)
relative to its use in studies (n=22), which may be attributed to the
paper's wider discussion of the importance of distinguishing high (but
non-problematic) engagement from addiction (Billieux, Flayelle,
Rumpf, & Stein, 2019; Charlton & Danforth, 2007). Only two GD-spe-
cific tools (i.e., the AICA-Sgaming and VAT) have been used in both a
national prevalence study and an intervention study. Overall, the YIAT,
YDQ, and GAS-7 have been the most widely used and cited GD tools;
however, none of these tools provide total coverage of the DSM-5 or
ICD-11 criteria.
Table 4
Sample size and recruitment for studies using the reviewed tools (n= 24a), ranked by total N.
Tool Studies Total N Adol. Adult Conv. Non-Conv. %Adol %Non-Conv.
GAS-7 45 94,389 22,616 69,789 38,393 55,618 24.0 58.9
YIAT 62 49,509 1973 47,536 16,347 31,592 4.0 63.8
CIUS-14 12 46,235 11,763 26,340 22,334 23,901 25.4 51.7
AICA-Sgaming 18 36,306 28,447 7859 5211 31,095 78.3 85.7
YDQ 12 30,916 29,810 1106 1106 29,810 96.4 96.4
PVP Scale 22 26,260 7626 18,634 6527 19,066 29.0 74.5
CSAS 2 26,171 26,717 0 0 26,171 100 100
IGDS9–SF 24 25,503 8894 14,609 22,432 1071 34.9 4.2
IGDT-10 7 21,702 8883 12,819 21,702 0 40.9 0
Lemmens IGD-9 16 19,865 10,197 9668 12,910 6955 51.3 35
POGQ-SF 6 18,366 14,809 3557 3557 14,809 80.6 80.6
VAT 7 13,478 13,198 0 1826 11,372 97.9 84.3
POGQ 8 9585 2524 7061 9585 0 26.3 0
A-EQ 17 8113 3332 4781 4781 3332 41.1 41.1
GAS-21 16 5807 1676 4131 5500 88 29.9 1.5
IGD-20 8 5454 930 4524 4379 1075 17.1 19.7
Petry IGD 13 4728 861 3867 4542 186 18.2 3.9
BAM-VG 2 4448 0 4448 506 3942 0 88.6
IGUESS 4 3796 3796 0 0 3796 100 100
GAIT 4 3745 3745 0 0 3745 100 100
Lemmens IGD-27 2 2901 2444 457 2444 457 84.3 15.8
sIATgaming 8 2625 0 2625 2625 0 0 0
POGU 2 1505 1442 63 1505 0 95.8 0
PIE-9 3 842 0 842 842 0 0 0
Total 320 462,249 205,683 244,716 189,054 268,081 44.5 58.0
Adol.: N of participants aged <18 years. Adult: N of participants aged 18+ years. Conv.: Convenience sample N. Non-Conv.: Non-convenience sample N. Includes
nationally representative studies, cohort studies, randomly selected samples, treatment-seeking populations. NB: Studies with undifferentiated samples of adolescents
and adults are included in ‘Total N’ but not listed in other columns. Underlined, bold: Largest N in column. For % columns, the highest value with 10+ studies is
bolded and underlined.
a Tools not listed due to 1 study only: SCI-IGD, VASC, C-VAT2.0, GAIA, DIA, CIUS-8, CIUS-5, SSBA.
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3.4. Samples and recruitment strategies
Table 4 presents a summary of the age composition of, and re-
cruitment strategies for, samples in empirical studies of most GD tools
(n=24). For this table, tools with only 1 study (n=8) were excluded
due to insufficient cases to yield meaningful proportions. Overall, the
total N for all identified studies was 462,249 participants, of whom 56%
were aged 18 years or older. The GAS-7 has been administered to more
participants (n=94,389) than any other tool, including the greatest
number of participants recruited using non-convenience sampling
(n=55,618). Studies employing the YIAT and YDQ also reported re-
latively high figures for total N (n=49,509 and n=30,916, respec-
tively) and for participants recruited by non-convenience sampling
(n=31,592 and n=29,810, respectively). The AICA-Sgaming was
noteworthy for its relatively large evidence base (n= 18, including 10
studies with clinical samples), fourth highest total N (36,306), and the
highest percentage of non-convenience sampling (85.7%) among the
overall most frequently used tools (i.e., ranked 4th after the GAS-7,
YIAT, and CIUS-14). Some tools (i.e., IGDS9-SF, GAS-21, and Petry IGD)
have been administered to a relatively large number of participants, but
these studies are predominantly based (i.e., >95% of total N) on con-
venience samples (e.g., online self-selected, non-representative sam-
ples). Only the IGUESS tool has total coverage of the DSM-5 and ICD-11
criteria along with an evidence base composed of samples obtained by
non-convenience sampling; all other DSM/ICD-compatible tools are
based on evidence with 95% convenience sampling.
As a supplementary analysis, all sample figures were examined ac-
cording to the DSM-5 criteria covered by the tools they had been ad-
ministered in their respective studies (i.e., based on Table 2 results).
The objective of this analysis was to determine the extent to which
study participants had been able to respond (e.g., affirmatively, nega-
tively) to specific items referring to GD symptoms. The total N in each
study corresponding to each tool was assigned to each of the relevant
DSM-5 symptoms covered by each tool. For example, the GAS-7 had
been administered to 94,389 participants, and therefore the value
94,389 was assigned to its measurement of symptoms of preoccupation,
withdrawal, tolerance, etc. This process yielded an estimated total
number of participants with the possibility of responding to any given GD
symptom (e.g., assuming the item on the survey was completed).
This evaluation showed that, overall, items referring to pre-
occupation, withdrawal, unsuccessful attempts, and harm had been
administered to >96% of participants across the 320 studies. However,
items measuring continued use despite harm (i.e., the DSM-5 and ICD-
11 criterion) had been administered to only 11.9% of participants.
Similarly, items measuring tolerance (67.6%), loss of interests (58.5%),
and deception (48.3%) had been administered to relatively fewer par-
ticipants across studies. When selecting only those studies with non-
convenience samples, these figures were relatively similar across these
symptoms (i.e., less than 4% difference), except for the item on con-
tinued use despite harm, which reduced from 11.9% to 1.9%. Only
5053 participants out of the 268,081 participants in non-convenience
samples had been administered a tool with an item referring to con-
tinued use despite harm, indicating that this symptom was under-
represented in the literature.
3.5. Psychometric properties of tools
Table 5 presents the first of two summaries of the psychometric
properties of the 32 tools based on their 320 empirical studies. The
table summarizes the research evidence on test dimensionality, relia-
bility, and test refinement. Most GD tools (n=27) have been examined
using factor analytic techniques (or principal component analysis), but
there are inconsistencies across tools in terms of factor analytic (FA)
approach. Only 9 tools (i.e., POGU, POGQ, IGD-20, Petry IGD, Lem-
mens IGD-9 and IGD-27, YDQ, and CIUS-214) have been examined by
exploratory followed by confirmatory factor analysis (i.e., EFA and CFA
conducted in independent subsamples) within the same study. The
majority (n=21) of tools have been subjected to CFA only, with most
studies providing the a priori reasoning that GD is a unidimensional
construct. The majority of FA studies (n=47) reported that the GD
construct is unidimensional (i.e., commonly referring to the GD con-
struct composed of nine DSM-5 criteria, with the caveat that most tools
actually assess fewer than 9 criteria; see Table 2). There was minimal
empirical support for other dimensional structures (e.g., 2-factor solu-
tions; n=3 studies). Some tools demonstrated mixed and/or weak
support for their factor structure (e.g., VAT, IGD-20, sIATgaming, YIAT-
20, and CIUS-14).
Internal consistency was generally high across the 31 tools (i.e., this
was not reported for SCI-IGD). With the exception of the BAM-VG,
GAIA, VASC, CIUS-5, CIUS-8 and SSBA tools which had only 1 study
reporting on internal consistency, each tool had at least two in-
dependent studies reporting Cronbach's alpha values of at least 0.80.
Considerably fewer tools (n=7; 9 studies) had examined test-retest
reliability; in 8 of these 9 studies, the observed values from a 14-day or
30-day retest were satisfactory. The BAM-VG had a 0.73 test-retest re-
liability over a period of 90 days. There were 8 tools (i.e., GAS-7, POGQ,
POG-SF, VAT, IGDS9-SF, IGDT-10, CIUS-14, CIUS-8) that had been
evaluated by test-refinement analyses (e.g., IRT, Rasch analysis).
Generally, these analyses provided support for the model fit and mea-
surement invariance of each respective test. However, the IGDS9-SF
reported mixed results for measurement invariance across cultural
groups; it bears noting that these data were based largely (>95%) on
convenience sampling, which may have affected analyses.
Table 6 summarizes the research evidence on test validity, re-
lationship to impairment, and clinical use of each tool. Convergent
validity has often been operationalized in the GD literature as the bi-
variate association between gaming behavior (i.e., hours per week
spent gaming) and total score on a GD tool. The research team discussed
and agreed that habitual gaming for long periods (e.g., 6 to 8 h per day,
or longer) was typical in the context of GD, and acknowledged that this
behavioral pattern may fluctuate and that the condition was often
episodic, but did not consider this association to be generally defining.
Gaming may occur for some individuals as a regular and relatively
frequent activity without reported associated major negative con-
sequences, as described in previous studies (Király, Tóth, Urbán,
Demetrovics, & Maraz, 2017; Triberti et al., 2018). King, Haagsma,
et al., 2013; King, Delfabbro, et al. (2013) review reported the GD-
gaming time association for convergent validity; therefore, it is re-
produced with caution in this review. Overall, there were varied results
on the association between gaming time and total GD tool score, with
reported values largely ranging from 0.2 and 0.4 (i.e., small to mod-
erate effect; Cohen, 1992).
Criterion validity was evaluated by examining the association be-
tween scores on each GD tool and other similar or closely related tools
(e.g., measures of gaming-related craving or maladaptive gaming-re-
lated cognitions). Most tools (n=28) have been examined in relation
to other GD tools, particularly the YIAT (n=8 tool comparisons). The
GAS-21, VAT, and the IGDS9-SF have reported the most consistently
high correlations with other GD tools. Aside from the YIAT's consistent
convergent validity results across 11 studies, the IGDS9-SF was note-
worthy for having 5 studies employing 4 different GD tools (i.e., GAS-7,
IGD-20, Lemmens IGD-9, and YIAT) that reported associations ex-
ceeding r=0.70.
Only 6 tools (n=9 studies) have been examined in conjunction
with standardized measures of functional impairment or quality of life.
The PIE-9 was the only tool that has been evaluated using the re-
commended standard disability/impairment assessment (i.e., the World
Health Organization-Disability Assessment Schedule [WHO-DAS]). The
IGD-20 has been examined in conjunction with the DSM global clinician
rating scale (i.e., General Assessment of Functioning [GAF]). Other
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tools (i.e., the A-EQ, GAS-7, Lemmens IGD-9, and YIAT) have been
evaluated using standardized quality-of-life measures.
Eleven tools have been employed in studies involving a clinical
interview. Notably, the AICA-Sgaming (n=11) and the YIAT (n=31)
have been used most frequently. The AICA-Sgaming and Petry IGD are
the two most commonly used gaming-specific tools within studies using
clinical interviews. In relation to GD tools measuring treatment out-
comes, only the YIAT (n=9 studies) and YDQ (n=2 studies) have
been used in more than one published study. Four other GD tools (i.e.,
the POGU, AICA-Sgaming, VAT, and IGD-20) have been employed in
one study only.
3.6. Quick reference guide to GD tools
Table 7 presents a synthesis of the main areas of evaluation of the 32
tools. This table was designed to provide a ‘quick guide’ for researchers
and clinicians, identifying tools with specific supporting evidence or use
in particular study types. In this way, the table aims to provide a con-
cise overview of the relative strengths and weaknesses for each tool,
with the caveats that this table presents: (1) an unweighted re-
presentation of data underlying each of the criteria, meaning that the
table does not differentiate between tools that meet certain score
thresholds (e.g., 2 studies) and those that greatly exceed this basic
threshold (e.g., not all tools that score 2 on ‘prevalence data’ should be
considered equivalent); (2) total scores in the rightmost column should
not necessarily be considered an overall indicator of tool quality (i.e.,
higher scores indicate the presence of research evidence in more areas,
not higher tool quality); and, (3) higher scores in some areas may be
undermined by weaknesses in other areas (e.g., tools with poorly
sampled studies are less likely to be valid).
Notwithstanding these limitations, the GD tools that fulfilled the
most scoring criteria were the GAS-7, IGDS9-SF, IGDT-10, YDQ and
Lemmens IGD-9. The GAS-7 is a much older gaming-specific tool and
precedes the DSM-5. Although the GAS-7 is still used frequently in re-
search, particularly in prevalence studies of European young people,
this tool has not yet been used in intervention studies. Only the IGDS9-
SF and IGDT-10 have DSM-5 and ICD-11 coverage, and only the YDQ
has been used in a study involving clinical interviewing or an inter-
vention. The IGDS9-SF and IGDT-10 had similar profiles in this eva-
luation, including basic length and scoring, and a comparably sized
evidence base (i.e., in terms of total N) predominantly based on con-
venience samples. Overall, there was a mixed picture of the evidence on
GD tools, with several tools with relatively higher evidential support in
distinct areas (e.g., GAS-7, Lemmens IGD-9, AICA-Sgaming, and IGDT-
10), but there was no markedly superior tool with distinct practical
and/or psychometric advantages.
4. Discussion
The present review aimed to systematically evaluate all available
instruments for GD. This work was intended to extend a previous major
review of GD tools by King, Haagsma, et al., 2013, which closely pre-
ceded the inclusion of GD as a condition for further study in the DSM-5.
The 2013 review highlighted conceptual inconsistencies across GD
tools, as well as gaps in empirical evidence underlying each measures'
psychometric properties. Seven years have passed since the preparation
of King, Haagsma, et al., 2013 report, and with the official inclusion of
GD as a diagnostic category in the ICD-11 in May 2019, it was con-
sidered timely to re-evaluate the state-of-the-art in GD screening and
assessment. Overall, this evaluation has found that the GD field has
greatly expanded in overall size and its array of GD-specific in-
strumentation, particularly since 2013, with at least 2 new tools, on
average, published in each subsequent year. The field has also con-
tinued to employ several internet-use-specific tools (e.g., the YIAT,
created in 1998) to screen for gaming-related problems, particularly in
East Asia. Overall, no single tool emerged from this evaluation as theTa
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clearly optimal choice. However, there were some relatively stronger
tools (i.e., the AICA-Sgaming, GAS-7, IGDT-10, IGDS9-SF, and Lemmens
IGD-9), identified on the basis of conceptual and/or practical con-
siderations and greater volume of evidential support for their psycho-
metric properties.
The GD field is growing rapidly on a global level. This systematic
review has identified 320 empirical studies that have employed a
combined total of 32 GD tools, with these studies conducted primarily
throughout Europe and East Asia. However, there still appears to be
some uncertainty or lack of agreement among GD researchers con-
cerning optimal approaches to screening and assessment, as indicated
by the continuing creation of new tools that vary in scope and content.
This review has identified inconsistencies in symptom coverage across
32 tools. Screening tools do not necessarily have to measure all cri-
teria or guidelines for any given condition, including GD, in order to
be effective. The objective is usually to capture the essential elements
of behaviors in a brief format. This review shows that most GD tools
tend to converge on the importance of screening for impaired control
over gaming and gaming behavior that jeopardizes a significant re-
lationship, or school or work opportunity. This means, however, that
there are some criteria or guidelines for GD that tend to be excluded
from tools. Notably, the criterion referring to continued use despite
harm (which is included in the DSM-5 and ICD-11 criteria) has ap-
peared in only 9 out of 32 tools. This review found that an estimated
88.1% of participants across 320 studies have not been administered a
survey item that captures this particular symptom. The 8 tools that
provide total coverage of both the DSM-5 and ICD-11 criteria (i.e.,
Petry IGD, IGDS9-SF, PIE-9, IGDT-10, SCI-IGD, CVAT2.0, IGUESS, and
DIA) have been used in a combined total of only 5 nationally re-
presentative prevalence studies, or 7% of the prevalence study lit-
erature. These observations raise the issue of adequate representation
of GD symptomatology in research, and whether these observed gaps
in measurement should be factored into current estimates of incidence
and prevalence.
Sixteen GD-specific tools have been created since the recognition of
IGD in the DSM-5 in 2013. However, many research teams have instead
opted to use other tools that precede the DSM-5. Notably, the YIAT and
YDQ measures have been used in numerous studies conducted within
China and South Korea, particularly those involving clinical interviews
to determine eligibility for neuroimaging evaluation and/or interven-
tions. Similarly, research teams in Europe have often employed the
GAS-7 for large-scale prevalence and cohort studies. The GD field
therefore appears to be shaped by two main types of researchers: (1)
those who continue to use older (i.e., pre-DSM-5) tools (i.e., the GAS-7,
YIAT, and YDQ) despite the availability of new tools and guidelines for
GD; and, (2) those who develop and attempt to validate their own tools
which are often conceptually and practically similar, i.e., a tool of be-
tween 10 and 20 items that measures a unidimensional addiction
construct derived from DSM-5 criteria. Further, regarding (2), the ma-
jority of new tools tend to be psychometrically evaluated exclusively by
the researchers who created them. The IGDT-10 and AICA-Sgaming are
the only post-DSM-5 tools that have been employed in a study designed
to validate psychometric properties by an independent research team.
This suggests that there is an isolationist quality to the field's collective
efforts to study GD. Many teams appear to be operating in research silos
rather than working collaboratively to develop a unified evidence base
around a smaller, more manageable subset of measures. Reaching a
consensus about the use of specific psychometrically validated
screening tools in studies worldwide would not only optimize pre-
valence estimates, but may also be helpful for studies addressing psy-
chological mechanisms underlying GD and for testing hypotheses on
these processes as suggested in theoretical models (e.g., Brand et al.,
2019; Dong & Potenza, 2014; Wei, Zhang, Turel, Bechara, & He, 2017).
For comparison, the field of gambling disorder, which like GD is a
disorder due to addictive behaviors recognized by the ICD-11 (albeit
with a more extensive academic history than GD), has coalesced aroundTa
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Table 7
Quick reference guide to all reviewed tools (n=32) for problematic gaming and gaming disorder.
Tool 1
. D
SM
-5
 c
ov
er
ag
e
2.
 IC
D
-1
1 
co
ve
ra
ge
3.
 C
ut
-o
ff
 s
co
re
4.
 V
al
id
at
io
n 
sa
m
pl
e
5.
 P
re
va
le
nc
e 
da
ta
6.
 L
on
gi
tu
di
na
l s
tu
di
es
7.
 D
im
en
si
on
al
ity
8.
 In
te
rn
al
 c
on
si
st
en
cy
9.
 T
es
t-
re
te
st
 re
lia
bi
lit
y
10
. C
ri
te
ri
on
 v
al
id
ity
11
. T
es
t r
ef
in
em
en
t
12
. I
m
pa
ir
m
en
t
13
. S
tr
uc
tu
re
d 
in
te
rv
ie
w
 
T
O
T
A
L
 S
C
O
R
E
 (/
23
)
PVP Scale 6
A-EQ 6
GAS-7 17
GAS-21 11
POGU 3
AICA-Sgaming 9
POGQ 6
VAT 8
POGQ-SF 7
sIAT-gaming 4
IGD-20 7
GAIA 2
Petry IGD 9
IGDS9–SF 16
Lemmens IGD-9 11
Lemmens IGD-27 7
GAIT 9
CSAS 7
PIE-9 10
BAM-VG 4
IGDT10 13
SCI-IGD 5
VASC 3
C-VAT2.0 5
IGUESS 10
DIA 6
YIAT 9
YDQ 12
CIUS-14 12
CIUS-8 7
CIUS-5 4
SSBA 4
Full score is 2 points, except for the criteria 1, 2 and 3, where full score is 1 point. Full score. Half-score. No score. Underlined values denote the tests with the
highest scores. See Table 1 for full test names.
Scoring criteria:
Criterion 1: Coverage of DSM-5 Internet gaming disorder criteria [0: Does not provide coverage of all DSM-5 IGD criteria. 1: Coverage of all DSM-5 IGD criteria.];
Criterion 2: Coverage of ICD-11 Gaming disorder criteria [0: Does not provide coverage of all ICD-11 criteria. 1: Coverage of all ICD-11 GD criteria.]; Criterion 3:
Cut-off score is present [0: No cut-off or unclear cut-off score. 1: Has a cut-off score.]; Criterion 4: Validation sample quality, indicated by psychometric properties
evaluated in a nationally representative or clinical sample [0: No available data; 1: At least one study; 2: at least 1 study, and another study undertaken by an
independent team]; Criterion 5: Prevalence data available [0: No available data. 1: Has 1 nationally representative prevalence study. 2: Has 2+ nationally
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8 main tools used between 2000 and 20151 (see Calado & Griffiths,
2016).
4.1. GD tools with greater evidential support
This review identified five GD tools that have a relatively greater
volume of evidential support for basic psychometric properties com-
pared to other tools. These tools are the GAS-7, IGDS9-SF, IGDT-10,
YDQ, and Lemmens IGD-9. However, no one tool appears clearly su-
perior because many of the tools have similar strengths (e.g., the GAS-7
and Lemmens IGD-9 had a comparable evaluation profile), and each
tool's limitations were offset by other positive attributes. Some tools are
untested in some contexts (e.g., treatment) or have not yet been eval-
uated psychometrically in some ways (e.g., item response theory). It
may be anticipated that future research will address some of these gaps.
On the other hand, given that research teams have tended to specialize
in particular research areas (e.g., epidemiological, neuroimaging,
treatment) and teams have often favored their own tools, some tools
appear unlikely to be evaluated in certain types of research. The AICA-
Sgaming, for example, has been used in at least 10 studies of treatment-
seekers, whereas 17 other tools have not been used in any research
involving clinical samples. This situation may eventually lead to di-
vergent streams of evidence for specific tools, such that some tools
become the standard for some study types but not others, thereby
complicating future tasks of synthesizing evidence across a broad lit-
erature.
The GAS-7 was the most frequently positively rated tool (N.B., not
to be conflated with psychometric superiority) due to its multiple po-
sitive features and large evidence base. Its research base included nu-
merous datasets from prevalence studies throughout Europe, good cri-
terion validity and reliability (internal, test-retest), and satisfactory
performance on test refinement analyses (e.g., measurement in-
variance). However, the GAS-7 has not been used clinically, and
therefore its utility as an outcome measure in treatment, or sensitivity
to treatment-related changes, has not been investigated. In addition, the
GAS-7 has incomplete coverage of DSM-5 and ICD-11 criteria, which
may not be essential for screening purposes but remains noteworthy as
the field turns its attention to locating measurement approaches con-
sistent with ICD-11 classification. This may include research initiatives
that involve developing new screening tools for behaviors that appear
to have overlapping features with gaming (e.g., online social media use)
by adapting items from existing GD tools.2
Of the 5 tools with the broadest empirical support as identified in
Table 7, the IGDS9-SF and IGDT-10 were the only tools that provided
total coverage of the DSM-5 and ICD-11 criteria. The IGDS9-SF and
IGDT-10 had similar profiles in this evaluation, including number of
items and scoring approach, and a comparably sized evidence base (i.e.,
in terms of total N). Both tools were limited by their study samples;
most studies (i.e., 23 out of 24) that employed the IGDS9-SF involved
convenience samples, and the IGDT-10 has exclusively been used in
convenience samples (i.e., all 7 studies). The IGDT-10 is noteworthy,
however, for its numerous language translations and use in relatively
more countries, notably China and Japan (N.B., only 2 of the 32 tools
have been translated into Japanese). Therefore, the IGDT-10 seems well
positioned to bridge the research divide between Western and Eastern
countries that is common in the GD literature. With regard to Eastern
research, the YIAT and YDQ tools were most commonly used in Chinese
studies (i.e., those published in English), which stands in contrast to
most research teams across Western countries that now rarely employ
these two tools.
4.2. Implications for debates on GD evidence
The present review provides insights that should contribute to on-
going debate on the general quality and attributes of the GD literature.
For example, some critics have asserted that the GD evidence base is
flawed due to its reliance on convenience samples. A recent 37-author
debate paper by van Rooij et al. (2018), entitled “A weak scientific basis
for gaming disorder” argued against the inclusion of GD in ICD-11 on the
basis that scientific standards had not been met. Among other issues
raised, the authors argued that sampling approaches were inadequate
because studies recruited “healthy high-school/college students or non-
representative online samples recruited from Internet gaming forums”
(p.3). The authors also referred to the example of a Singaporean da-
taset, published in, 2011 (Gentile et al., 2011) and subsequently used in
multiple publications without cross-attribution of the data, to support
their contention that the literature suffered from “poor methodological
choices that undermine our confidence in the findings” (van Rooij et al.,
2018, p.4). While it is necessary that authors cite specific examples for
academic arguments, it is important that such examples do not form the
basis for unwarranted generalizations that may then be misconstrued as
scientific consensus. The present review's findings did not support this
particular criticism regarding sampling. Based on 320 GD studies of
which the majority report independent datasets, there was actually a
slight majority of participants (N=268,081 or 58% of all participants)
recruited using non-convenience sampling methods (e.g., nationally
representative studies, stratified sampling by age, region, urbanicity,
and treatment-seekers). It is inaccurate to conclude, therefore, that the
GD evidence as a whole is fundamentally flawed or “weak” as a con-
sequence of its recruitment strategies and sample sizes. Indeed, the
present review may provide a useful resource for other matters of de-
bate concerning the size and quality of GD evidence.
4.3. Future research directions
This review suggests some potential future research avenues to
improve GD assessment. As recommended by King, Haagsma, et al.,
2013; King, Delfabbro, et al. (2013), there is a continued need for high-
quality epidemiological and intervention studies, including within
these studies with a focus on sensitivity/specificity estimates. Studies of
representative studies.]; Criterion 6: Longitudinal data available [0: No available data. 1: Has 1 longitudinal study. 2: Has 2+ longitudinal studies.]; Criterion 7:
Dimensionality assessed by exploratory factor analysis and confirmatory factor analysis in two independent samples [0: No available data. 1: 1 study. 2: 2+ studies];
Criterion 8: Internal consistency, as assessed by Cronbach's alpha [0: No available data. 1: 1 study reporting alpha >0.70. 2: 2+ studies reporting alpha >0.70];
Criterion 9: Test-retest reliability [0: No available data. 1: 1 study with alpha >0.70. 2: 2+ studies with alpha >0.70]; Criterion 10: Criterion validity, as assessed
by association with other GD/IGD tests [0: No available data. 1: 1 study reporting association reporting 0.3 or higher. 2: 2+ studies reporting association 0.3 or
higher.]; Criterion 11: Rasch or Item Response Theory [0: No available data. 1: At least 1 study that reports strong support for items/model fit using Rasch or IRT
analysis. 2: At least 1 study that gives strong support for items/model fit using Rasch or IRT analysis, and 1 study undertaken by independent research team.];
Criterion 12: Test is significantly related to validated measure of functional impairment [0: No available data. 1: 1 study with correlation of at least 0.3. 2: 2+ studies
with correlation of at least 0.3]; Criterion 13: Test used in conjunction with structured/semi-structured interview involving a sample of treatment-seeking gamers or
problem gamers with evidenced functional impairment [0: No available data. 1: 1 study; 2+ studies.]
1 These 8 tools are the South Oaks Gambling Screen (SOGS), Problem
Gambling Severity Index (PGSI), DSM-IV criteria for pathological gambling,
Diagnostic Interview Schedule (DIS) for pathological gambling, Diagnostic
Interview for Gambling Severity (DIGS), National Opinion Research Center
DSM Screen for Gambling Problems (NODS), Gamblers Anonymous Twenty
Questions (GA20), and the Lie/Bet scale.
2 See recent papers on ‘scope creep’ (Haslam, 2016) and confirmatory bias in
connection to the study of behavioral addictions (Billieux, Schimmenti,
Khazaal, Maurage, & Heeren, 2015).
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gaming behavior should include consistent measures of comorbidity
(e.g., to address questions regarding the presence of other mental dis-
orders, such as depression, anxiety, attention-deficit/hyperactivity or
other factors such as past trauma that may affect risk of GD). Similarly,
future work should consider not only addictive aspects, but also other
relevant perspectives and concepts related to understanding repetitive
behaviors, notably impulsivity and compulsivity, in further developing
and refining instruments and diagnostic criteria. Non-problematic
gaming habits, as well as diagnostically subthreshold entities such as
‘hazardous gaming’ (QE22) in the ICD-11, deserve closer attention
(Potenza, 2018). The focus of most studies of GD has been on the
harmful consequences of gaming, without taking into account the po-
tential benefits of gaming activities for some individuals. GD symptoms
and negative consequences of gaming should be weighed against re-
ported benefits of gaming, particularly at lower levels of problematic
gaming (e.g., meeting between 1 and 4 DSM-5 criteria). This may de-
termine whether some individuals classified within ‘low risk’ categories
might in fact report that gaming has a net benefit on their quality of life
and psychological wellbeing or whether this sub-diagnostic level is
associated with more mental health concerns, as is typically the case in
gambling disorder (Desai & Potenza, 2008).
Another avenue for future research is the use of player data in
combination with GD tools and related measures. The field has often
relied on self-report approaches to validate tools, which has unavoid-
able limitations (e.g., biased recall, denial/defensiveness, lack of in-
sight). Conventional survey and interview approaches may be supple-
mented by player data to provide an objective historical account of
gaming behavior; i.e., to describe or corroborate patterns of behavior
that may otherwise be difficult to recall. Such data may be acquired by
using an app-like or similar monitoring device or software.
Considerations regarding how to work together with groups from the
gaming industry warrant transparent discussion in order to help ensure
scientific integrity in academic/industry collaborations (Griffiths &
Pontes, 2019; King, Delfabbro, Deleuze, et al., 2019; King, Delfabbro,
Gainsbury, et al., 2019). Another area for future research concerns the
evolving technological nature of modern online video games, particu-
larly the monetization of in-game content (e.g., in-game purchasing,
microtransactions, and ‘loot boxes’; see King, Delfabbro, Deleuze, et al.,
2019; King, Delfabbro, Gainsbury, et al., 2019; Zendle & Cairns, 2018).
Problematic gaming that involves interactions with monetized content
may be more financially involved and share features in common with
gambling disorder (e.g., spending more than one can afford, borrowing
or stealing money) (King & Delfabbro, 2018; King, Delfabbro, Deleuze,
et al., 2019; King, Delfabbro, Gainsbury, et al., 2019). GD tools may
need to reflect some of these structural elements in gaming activities,
such as additional questions to examine different behaviors and con-
sequences related to different types of games and modes of access (e.g.,
smartphones, virtual reality) (King, Koster, & Billieux, 2019). The
measurement of more in-depth player and gaming information (e.g.,
game types) is beyond the scope of screening approaches, but is suited
to a semi-structured diagnostic interview for GD (i.e., akin to the
Structured Clinical Interview for DSM or Mini International Neu-
ropsychiatric Interview), which could be developed and used inter-
nationally.
4.4. Limitations of the review
The present review has several limitations that should be ac-
knowledged. First, this review was based on English-language studies
only, which excluded a significant proportion (i.e., potentially, the
majority) of the East Asian literature (i.e., studies in Chinese, Korean,
and Japanese, in particular). This review also did not include data from
studies published in German, Dutch, and French. Although researchers
working in these countries often publish their work in English journals,
the potential omission of relevant data is likely to have affected the
evaluation of tools originating from these regions, e.g., the AICA-
Sgaming, CSAS, GAS-7, and sIAT-gaming. Similarly, in some countries,
there is a substantial grey literature (e.g., government-led health sur-
veys that include standard GD questions), which was not included in
this review. This review also did not include studies that employed
“adapted” DSM-5 criteria, which would not have affected the main
evaluation of tools, but should be taken into account when considering
this review's observations of the broader GD literature (e.g., total
number of prevalence studies). The review framework aimed to be
more comprehensive than any previous review but there were still some
gaps. This review did not consider, for example, the sensitivity/speci-
ficity of tools, because: (1) this information was very rarely reported;
and, (2) the external standard was not always clear in relevant studies.
Other areas that were not evaluated were predictive and divergent
validity, due to inconsistencies in reporting that made it difficult to
extract these data. This review takes into consideration the current
conceptualizations of GD and IGD, which may be revised as more evi-
dence accumulates. Finally, the review framework itself was limited by
the fact that many of the criteria were inter-related and often affected
by other considerations (e.g., sampling method, sample size).
4.5. Conclusions
The inclusion of GD in the ICD-11 was a significant milestone for the
field. The GD diagnosis is likely to stimulate new research investiga-
tions on a global level, in important areas of epidemiology, neuro-
biology, treatment, prevention and public health. The present review
aimed to inform the next era of research by providing a comprehensive
evaluation of all available English-language GD tools, including a cri-
tical appraisal of their associated empirical evidence. The framework
employed in this review may be useful for scale evaluation in other
areas. Overall, this evidence was found to be mixed, with no clearly
optimal tool among 32 tools used across Western and Eastern countries.
While the research base has grown rapidly and largely improved its
methodologies, the field is hindered by the overproduction of con-
ceptually similar tools which have divided research efforts and created
uncertainty among researchers. Despite the abundance of new in-
strumentation, some tools have relatively greater evidential support for
their psychometric properties, including the GAS-7, IGDS9-SF, IGDT-
10, and Lemmens IGD-9. Given that most new tools were developed
following the inclusion of the provisional DSM-5 criteria, it seems likely
that researchers will again “rush to market” to develop new tools that
purportedly measure the new ICD-11 GD classification. For the field to
prosper and attain greater legitimacy in the field of addiction studies, a
more unified approach to measurement is important. Isolated research
that creates a multiplicity of tools generates an incohesive and less
convincing evidence base. The development of a gold standard tool,
following past examples of screening for use of addictive substances
(e.g., Saunders, Aasland, Babor, De la Fuente, & Grant, 1993; ASSIST;
WHO ASSIST Working Group, 2002), would be invaluable for steering
this nascent field toward achieving valid identification of gaming-re-
lated harms, and developing more effective intervention strategies for
those in need.
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